Recombinant Human DGAT2 Protein，His

DGAT2 (Diacylglycerol O-acyltransferase 2) is a critical enzyme involved in lipid metabolism, playing a pivotal role in triacylglycerol (TAG) synthesis. Its importance lies in the growing concerns surrounding metabolic disorders, obesity, and related diseases, as TAG accumulation is closely linked to these conditions. Research on DGAT2 has gained momentum due to its potential as a therapeutic target for treating lipid-related diseases. Understanding the structural and functional characteristics of DGAT2 through recombinant protein studies is essential, as it allows researchers to elucidate its enzymatic mechanisms and interactions with other proteins and substrates. Recombinant DGAT2 proteins serve as invaluable tools for investigating substrate specificity, inhibition mechanisms, and the effects of genetic variations on enzyme activity. Furthermore, these studies can enhance our knowledge about lipid storage and mobilization processes, potentially leading to novel strategies for managing fatty liver disease and metabolic syndrome. The successful expression and purification of DGAT2 in heterologous systems facilitate detailed biochemical assays and structural analyses, paving the way for the development of small-molecule inhibitors or modulators that could regulate its activity in vivo. Thus, the research on DGAT2 recombinant proteins is crucial for both fundamental science and the advancement of clinical applications aimed at addressing lipid dysregulation.